Justin Johnson retweeted
Opus 5.5 is a really good model. It's been my daily driver the last few weeks.
We had Opus 5.5 and Fable 5.1 each port HAProxy from C to Rust. Both passed nearly all of HAProxy's tests, but Opus 5.5 finished in 9.5 hours compared to Fable 5.1's 12 hours, and for 51% less cost.
This is one of the most useful writeups I have seen on keeping an LLM judge effective in production.
(bookmark it)
Netflix runs judges over hundreds of thousands of show-level recommendation explanations per week, served to millions of members on mobile.
They describe the judge as a lifecycle with four phases rather than an artifact that you only validate once.
> Birth defines multiple evaluation criteria and builds curated benchmarks with human labels and rationales.
> Training refines the judge's rubric through Reasoning-Aligned Rubric Tuning, using a meta-judge over reasoning output as the learning signal.
> Deployment puts one judge in two roles, quality gating and reflective generation.
> Monitoring runs continuous human-in-the-loop alignment that detects drift and triggers re-tuning behind a review gate.
A five-week A/B test over tens of millions of members shifted viewing toward previously unwatched content and increased successful browse-to-play sessions against a no-explanation control, with no quality-related takedowns.
Paper: arxiv.org/abs/2608.18300
Track more trending AI papers in our academy: academy.dair.ai/
Justin Johnson retweeted
A in-depth review of AI for drug discovery
"It can be concluded that we are still at a stage with an ‘absence of evidence’ (and not necessarily an 'evidence of absence') when it comes to the translation of AI into clinically relevant impact." @NatRevDrugDisc
nature.com/articles/s41573-0…





